<DOC>
	<DOCNO>NCT01870440</DOCNO>
	<brief_summary>The purpose study determine whether intravitreal dexamethasone implant ( Ozurdex , Allergan ) effective manage macular edema secondary non-infectious uveitis .</brief_summary>
	<brief_title>TAHOE : Intravitreal Dexamethasone Implant ( Ozurdex ) Uveitic Macular Edema</brief_title>
	<detailed_description>Uveitis account 10 % case severe vision loss develop country , make possibly fourth lead cause blindness United States . Cystoid macular edema ( CME ) structural complication uveitis , result visual impairment blindness . If leave untreated undertreated period year , CME may result permanent photoreceptor damage macula loss central vision . Further , CME may persist despite adequate control uveitis , therefore , adjuvant therapy specifically treat CME may require . We propose study whether sustain steroid delivery system ( Ozurdex , Allergan ) treat uveitic macular edema . Ozurdex proven effective non-infectious posterior uveitis ; FDA approve posterior uveitis . The sustained delivery steroid local delivery modality make ideal candidate manage macular edema uveitis .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Uveitis CME central subfoveal thickness &gt; 350 micron noninfectious uveitis Visual Acuity &gt; 20/32 Visual Acuity worse 20/200 Moderate severe glaucoma ( define &gt; 2 topical ocular medication ) Infectious uveitis Patients active suspect ocular periocular infection include viral disease cornea conjunctiva , include active epithelial herpes simplex keratitis , vaccinia , varicella , mycobacterial infection , fungal disease . Aphakic eyes rupture posterior lens capsule Anterior Chamber intraocular Lens rupture posterior lens capsule Hypersensitivity component Ozurdex</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Uveitis</keyword>
	<keyword>Macular Edema</keyword>
</DOC>